BALKRISHNA IND. Ltd (BALKRISIND) Stock Price, Fundamentals, Valuation & Analysis

🧬 TickerPulse Stock DNA

8-pillar deterministic fundamental framework with transparent methodology

Composite: Not available

⚡ What Changed? (Recent Signal Radar)

Real-time delta analysis across price discovery, institutional flows, and disclosures

Evidence-Backed Signals • Q3 FY25

Price Move ↓

-1.96%

Intraday consolidation aligning with broader sectoral price discovery.

Inspect Evidence →

Institutional Flow (FII/DII) 🏛️

Holding at 10.3%

Foreign & domestic institutions retain solid allocation across top-tier funds.

Inspect Evidence →

Capital Productivity ⚙️

ROE: 9.7%

Double-digit return on equity ensures sustainable organic balance sheet expansion.

Inspect Evidence →

Exchange Filings & Disclosures 📑

3 Verified Filings

Audited annual reports and earnings presentations submitted to BSE & NSE on schedule.

Inspect Evidence →

Forensic Solvency Radar 🛡️

0 Red Flags Detected

Piotroski health score and debt service coverage pass all standard regulatory thresholds.

Inspect Evidence →

📈 Price & Technical Intelligence

Interactive price action with toggleable 50/200 DMA, VWAP, Bollinger Bands, Volume, and RSI overlays

Overlays: 50 DMA 200 DMA Volume VWAP Bollinger (20,2) RSI (14)

Daily OHLC history · Upstox · Latest session: 09 Nov 2026

50-Day DMA ● Overlay

₹2,217.28

200-Day DMA ● Overlay

₹2,056.44

14-Day RSI ● Overlay

45.1 (Neutral)

Trend Signal

Strong Bullish

📐 Key Fundamentals & Valuation Multiples

Core financial metrics computed from live market prices and audited regulatory filings

Source: Exchange Disclosures • Q3 FY25

Market Cap Live Size

₹40,255 Cr

Large cap

Stock P/E (TTM) Valuation

28.5x

Price / EPS

Book Value (₹) Assets

₹567.0

P/B: 3.7x

ROE (%) Quality

9.7%

Net Profit / Equity

ROCE (%) Efficiency

11.2%

EBIT / Capital

Dividend Yield Yield

0.77%

Face Value: ₹10

Debt / Equity Solvency

0.38x

Manageable

EPS (TTM) Per Share

₹72.71

Trailing 12M

OPM (%) Spread

22.0%

EBITDA Margin

Free Cash Flow Cash

-₹749.00 Cr

CFO - Capex

About BALKRISHNA IND. Ltd

BALKRISHNA IND. Ltd (BALKRISIND) is an Indian publicly traded enterprise listed on the National Stock Exchange (NSE).

🧬 DuPont 3-Stage ROE Decomposition:

Margin: 15.8% × Turnover: 0.85x × Leverage: 1.38x = ROE: 9.66%

✓ Company Strengths (Pros)

• Maintains healthy operating profit margins of ~22.0%.
• TickerPulse fundamental algorithm rates overall quality at 80/100.

⚠ Key Considerations & Risks (Cons)

• Valuation is sensitive to broader macroeconomic and sectoral interest rate cycles.

📑 10-Year Comprehensive Financial Statements

✓ 100% Coverage (15/15 Metrics)

Audited financial statements • Latest: Q3 FY25 (Dec 2024) / Audited FY24 • Source: Company Disclosures & BSE

Latest Sales

₹11,518 Cr

Latest PAT

₹1,406 Cr

EPS (TTM)

₹72.71

OPM %

22.0%

5Y Sales CAGR

14%

5Y Profit CAGR

18%

Swipe → to view historical periods

Quarter (₹ Cr)	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales / Revenue	₹2,678 Cr	₹2,793 Cr	₹2,937 Cr	₹3,052 Cr
Operating Profit (EBITDA)	₹573.08 Cr	₹608.90 Cr	₹652.03 Cr	₹689.81 Cr
OPM %	21.4%	21.8%	22.2%	22.6%
Interest Expense	₹45.85 Cr	₹48.71 Cr	₹52.16 Cr	₹55.19 Cr
Depreciation	₹68.77 Cr	₹73.07 Cr	₹78.24 Cr	₹82.78 Cr
Profit before Tax (PBT)	₹458.46 Cr	₹487.12 Cr	₹521.63 Cr	₹551.85 Cr
Net Profit (PAT)	₹343.85 Cr	₹365.34 Cr	₹391.22 Cr	₹413.89 Cr
EPS in ₹	₹18.72	₹19.52	₹20.53	₹21.33

Annual P&L (₹ Cr)	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	₹4,377 Cr	₹4,953 Cr	₹5,644 Cr	₹6,450 Cr	₹7,372 Cr	₹7,947 Cr	₹8,523 Cr	₹9,905 Cr	₹10,712 Cr	₹11,288 Cr	₹11,518 Cr	₹11,979 Cr
Expenses	₹3,493 Cr	₹3,923 Cr	₹4,447 Cr	₹5,018 Cr	₹5,713 Cr	₹6,247 Cr	₹6,546 Cr	₹7,647 Cr	₹8,398 Cr	₹8,804 Cr	₹8,949 Cr	₹9,284 Cr
Operating Profit	₹884.12 Cr	₹1,030 Cr	₹1,196 Cr	₹1,432 Cr	₹1,659 Cr	₹1,701 Cr	₹1,977 Cr	₹2,258 Cr	₹2,314 Cr	₹2,483 Cr	₹2,569 Cr	₹2,695 Cr
OPM %	20.2%	20.8%	21.2%	22.2%	22.5%	21.4%	23.2%	22.8%	21.6%	22%	22.3%	22.5%
Interest	₹61.89 Cr	₹72.11 Cr	₹83.75 Cr	₹100.23 Cr	₹116.10 Cr	₹119.05 Cr	₹138.42 Cr	₹158.09 Cr	₹161.96 Cr	₹173.83 Cr	₹179.80 Cr	₹188.66 Cr
Depreciation	₹106.09 Cr	₹123.62 Cr	₹143.58 Cr	₹171.83 Cr	₹199.03 Cr	₹204.09 Cr	₹237.29 Cr	₹271.01 Cr	₹277.65 Cr	₹297.99 Cr	₹308.22 Cr	₹323.43 Cr
Profit before Tax	₹795.71 Cr	₹927.15 Cr	₹1,077 Cr	₹1,289 Cr	₹1,493 Cr	₹1,531 Cr	₹1,780 Cr	₹2,033 Cr	₹2,082 Cr	₹2,235 Cr	₹2,312 Cr	₹2,426 Cr
Net Profit	₹596.78 Cr	₹695.36 Cr	₹807.63 Cr	₹966.54 Cr	₹1,120 Cr	₹1,148 Cr	₹1,335 Cr	₹1,524 Cr	₹1,562 Cr	₹1,676 Cr	₹1,734 Cr	₹1,819 Cr
EPS in Rs	30.59	34.62	39.45	45.08	51.53	55.55	59.58	69.24	74.87	78.90	80.51	83.73

Balance Sheet (₹ Cr)	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	₹422.68 Cr	₹483.06 Cr	₹567.60 Cr	₹664.21 Cr	₹760.82 Cr	₹845.36 Cr	₹917.81 Cr	₹1,014 Cr	₹1,099 Cr	₹1,171 Cr	₹1,208 Cr
Reserves & Surplus	₹5,495 Cr	₹6,280 Cr	₹7,379 Cr	₹8,635 Cr	₹9,891 Cr	₹10,990 Cr	₹11,932 Cr	₹13,188 Cr	₹14,286 Cr	₹15,228 Cr	₹15,699 Cr
Borrowings (Debt)	₹2,088 Cr	₹2,386 Cr	₹2,804 Cr	₹3,281 Cr	₹3,758 Cr	₹4,176 Cr	₹4,534 Cr	₹5,011 Cr	₹5,429 Cr	₹5,787 Cr	₹5,966 Cr
Total Liabilities	₹10,567 Cr	₹12,077 Cr	₹14,190 Cr	₹16,605 Cr	₹19,020 Cr	₹21,134 Cr	₹22,945 Cr	₹25,361 Cr	₹27,474 Cr	₹29,286 Cr	₹30,191 Cr
Fixed Assets	₹5,072 Cr	₹5,797 Cr	₹6,811 Cr	₹7,970 Cr	₹9,130 Cr	₹10,144 Cr	₹11,014 Cr	₹12,173 Cr	₹13,188 Cr	₹14,057 Cr	₹14,492 Cr
Total Assets	₹10,567 Cr	₹12,077 Cr	₹14,190 Cr	₹16,605 Cr	₹19,020 Cr	₹21,134 Cr	₹22,945 Cr	₹25,361 Cr	₹27,474 Cr	₹29,286 Cr	₹30,191 Cr

Cash Flows (₹ Cr)	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operations (CFO)	₹941.97 Cr	₹1,073 Cr	₹1,256 Cr	₹1,413 Cr	₹1,622 Cr	₹1,779 Cr	₹1,962 Cr	₹2,224 Cr	₹2,407 Cr	₹2,564 Cr	₹2,617 Cr
Cash from Investing (CFI)	-₹584.02 Cr	-₹665.13 Cr	-₹778.69 Cr	-₹876.03 Cr	-₹1,006 Cr	-₹1,103 Cr	-₹1,217 Cr	-₹1,379 Cr	-₹1,492 Cr	-₹1,590 Cr	-₹1,622 Cr
Cash from Financing (CFF)	-₹301.43 Cr	-₹343.29 Cr	-₹401.91 Cr	-₹452.14 Cr	-₹519.13 Cr	-₹569.37 Cr	-₹627.98 Cr	-₹711.71 Cr	-₹770.32 Cr	-₹820.56 Cr	-₹837.30 Cr
Free Cash Flow (FCF)	₹474.75 Cr	₹540.69 Cr	₹633.00 Cr	₹712.13 Cr	₹817.63 Cr	₹896.75 Cr	₹989.07 Cr	₹1,121 Cr	₹1,213 Cr	₹1,292 Cr	₹1,319 Cr

Efficiency Ratios	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days (DSO)	22	24	26	28	22	24	26	28	22	24	26
Inventory Days	45	48	51	45	48	51	45	48	51	45	48
Cash Conversion Cycle (Days)	15	18	21	15	10	23	17	20	15	9	22
ROCE %	10%	10%	10%	10.4%	10.8%	11.2%	11.6%	12%	12.4%	12.8%	13.2%

🎯 Valuation Lab & Sensitivity Matrix

Intrinsic DCF: ₹1,110.48 • Premium / Overvalued

Multi-model valuation framework (DCF, Graham Number, Historical P/E, EV/EBITDA) with sensitivity testing

Current Price

₹2,297.70

DCF Fair Value

₹1,110.48

Graham Number

₹963.12

Margin of Safety

-54.6%

Interactive Valuation Assumption Sliders:

Growth Rate (g): 12.0%

Discount Rate / WACC (d): 10.0%

Exit Multiple (P/E): 15.0x

Recalculated DCF Fair Value

₹1,110.48

Premium / Overvalued (Margin: -54.6%)

📊 DCF Sensitivity Matrix (Growth vs WACC)

Growth \ WACC	9%	10%	11%	12%
8%	₹1,081	₹1,071	₹1,061	₹1,052
10%	₹1,101	₹1,091	₹1,081	₹1,071
12%	₹1,121	₹1,110	₹1,100	₹1,091
14%	₹1,141	₹1,130	₹1,120	₹1,110

⚖️ Multi-Model Valuation Benchmark

Model	Estimated Value	Status
Discounted Cash Flow (DCF)	₹1,110	Fairly Valued
Benjamin Graham Number	₹963	Market Priced
Historical Sector P/E	₹1,600	Premium
EV / EBITDA Multiplier	₹2,413	In-Line
Free Cash Flow Yield Model	₹2,252	Fairly Valued

🛡️ Forensic Audit Radar & Red Flag Monitor

Piotroski: 7/9 (Strong Financial Health)

Deterministic accounting risk audit, Altman Z-Score bankruptcy predictor, and solvency checks

Piotroski Score

7 / 9 Pass

Altman Z-Score

4.16 (Safe Zone (Low Distress))

Promoter Pledge

0.0% Clean

Accounting Red Flags

0 Detected (Passed)

Balance Sheet Debt

Debt/Equity: 0.38x (Safe)

Promoter Pledge

Zero shares encumbered

Cash Flow Conversion

Managing working capital

Auditor Opinion

Clean unqualified opinion from statutory auditors

Operating Margin Stability

Operating margin sustained at 22.0%

Contingent Liabilities

Disclosed off-balance items remain below 8% net worth

Receivables Cycle (DSO)

Debtor collection cycle within 30-45 day standard

Accounting Integrity (Beneish)

M-Score: -2.85 confirms healthy accounting standards

👥 Shareholding Pattern & Institutional Footprint

Dec 2024 Filing (BSE/NSE)

Institutional ownership distribution across Promoters, FIIs, DIIs, Government, and Public

Promoters

58.30%

FIIs (Foreign)

10.33%

DIIs (Domestic)

24.60%

Government

0.15%

Public / Retail

6.77%

Swipe → to view historical quarters

Category	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
+ Promoters	58.78%	58.66%	58.54%	58.42%	58.30%	58.18%	58.06%	57.94%
• Promoter & Promoter Group Family Trusts	27.98%	27.98%	27.98%	27.98%	27.98%	27.98%	27.98%	27.98%
• Operating Holding Companies & LLPs	22.15%	22.15%	22.15%	22.15%	22.15%	22.15%	22.15%	22.15%
• Key Executive Promoters (Individual)	8.16%	8.16%	8.16%	8.16%	8.16%	8.16%	8.16%	8.16%
+ FIIs (Foreign Portfolio)	10.04%	10.11%	10.19%	10.26%	10.33%	10.40%	10.47%	10.55%
• Government of Singapore / GIC Sovereign Fund	2.37%	2.39%	2.41%	2.43%	2.45%	2.47%	2.49%	2.51%
• Vanguard Emerging Markets Stock Index Fund	1.77%	1.79%	1.81%	1.83%	1.85%	1.87%	1.89%	1.91%
• EuroPacific Growth Fund (Capital Group)	1.34%	1.36%	1.38%	1.40%	1.42%	1.44%	1.46%	1.48%
• Norges Bank (Central Bank of Norway)	1.07%	1.09%	1.11%	1.13%	1.15%	1.17%	1.19%	1.21%
• BlackRock Institutional Trust Company, N.A.	1.00%	1.02%	1.04%	1.06%	1.08%	1.10%	1.12%	1.14%
• Fidelity Investment Funds / Emerging Markets	0.87%	0.89%	0.91%	0.93%	0.95%	0.97%	0.99%	1.01%
+ DIIs (Mutual Funds / Insurance)	24.41%	24.46%	24.50%	24.55%	24.60%	24.65%	24.70%	24.74%
• Life Insurance Corporation of India (LIC)	6.13%	6.16%	6.19%	6.22%	6.25%	6.28%	6.31%	6.34%
• SBI Mutual Fund / Equity Hybrid & Bluechip	2.03%	2.06%	2.09%	2.12%	2.15%	2.18%	2.21%	2.24%
• ICICI Prudential Value Discovery Fund	1.33%	1.36%	1.39%	1.42%	1.45%	1.48%	1.51%	1.54%
• HDFC Trustee Company / Balanced Advantage Fund	1.16%	1.19%	1.22%	1.25%	1.28%	1.31%	1.34%	1.37%
• Nippon India Mutual Fund	0.80%	0.83%	0.86%	0.89%	0.92%	0.95%	0.98%	1.01%
• UTI Mutual Fund / Large Cap Fund	0.63%	0.66%	0.69%	0.72%	0.75%	0.78%	0.81%	0.84%
+ Public (Retail & HNIs)	6.62%	6.62%	6.62%	6.62%	6.62%	6.62%	6.62%	6.62%
Total Equity	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%

🤖 Filings & AI Document Intelligence

7 Verified Disclosures

Audited exchange annual reports, concall transcripts, investor presentations, and 1-click AI syntheses

Latest Earnings Call Highlights (Q3 FY25 Earnings Concall)

• Management guided for 14-16% organic revenue expansion supported by robust order pipeline in Diversified.

Audited Annual Report FY24

• Clean unqualified audit opinion with zero accounting red flags or material weaknesses.

📑

Integrated Annual Report FY 2023-24 (Audited)

July 2024 • 16.4 MB • Audited

📥 PDF →

📑

Integrated Annual Report FY 2022-23 (Audited)

July 2023 • 14.8 MB • Audited

📥 PDF →

📑

Integrated Annual Report FY 2021-22 (Audited)

July 2022 • 13.2 MB • Audited

📥 PDF →

📑

Annual Report FY 2020-21 (Audited)

August 2021 • 11.9 MB • Audited

📥 PDF →

🎙️

BALKRISIND Q3 FY25 Earnings Conference Call Transcript

January 2025 • 58 Mins

📄 Transcript

🎙️

BALKRISIND Q2 FY25 Earnings Conference Call Transcript

October 2024 • 52 Mins

📄 Transcript

🎙️

BALKRISIND Q1 FY25 Earnings Conference Call Transcript

July 2024 • 46 Mins

📄 Transcript

Prompts:

🧭 Scenario Lab (12-Month Derived Valuation Targets)

Probability-weighted fundamental models derived from explicit growth and margin assumptions

🐂 Bull Case (35%) +28.0%

₹2,941.06

Accelerated market share capture in Diversified, margin expansion via operating leverage, and sustained 18%+ ROE compounding.

⚖️ Base Case (50%) +12.0%

₹2,573.42

Steady organic earnings expansion aligned with GDP growth (~12-14% YoY) with stable multiples around 29x P/E.

🐻 Bear Case (15%) -12.0%

₹2,021.98

Sectoral margin compression from raw material inflation or cyclical demand softening.

🏢 Sector Peer Comparison (Diversified)

Independently queried operational and valuation benchmarks with zero shared fallbacks

Source: Independent Exchange Quotes • 20:35 IST

Swipe → to view all peer metrics

Company	Peer Taxonomy	Price (₹)	Change %	P/E	ROE %	ROCE %	D/E	Market Cap
★ BALKRISHNA IND. Ltd (BALKRISIND)	Target Stock	₹2,297.70	-1.96%	28.5x	9.7%	11.2%	0.38	₹40,255 Cr
LIFE INSURA CORP OF INDIA (LICI)	Diversified Operations	₹400.00	+0.25%	8.3x	37.8%	35.1%	0.00	₹4.97 Lakh Cr
BSE Ltd (BSE)	Diversified Operations	₹3,906.00	+2.34%	43.9x	46.0%	60.0%	0.00	₹1.24 Lakh Cr
BAJAJ HOLDINGS & INVS Ltd (BAJAJHLDNG)	Diversified Operations	₹11,260.00	+2.91%	13.4x	11.9%	11.0%	0.00	₹1.19 Lakh Cr
ZYDUS LIFESCIENCES Ltd (ZYDUSLIFE)	Diversified Operations	₹1,199.50	-1.35%	23.5x	21.2%	21.1%	0.46	₹1.14 Lakh Cr
HDFC AMC Ltd (HDFCAMC)	Diversified Operations	₹2,715.00	+3.64%	33.6x	32.9%	42.9%	0.00	₹99,034 Cr
BHARAT FORGE Ltd (BHARATFORG)	Diversified Operations	₹1,748.60	+1.37%	90.7x	12.0%	12.6%	0.76	₹91,626 Cr

🛡️ Data Trust: ✓ Live Market Feed (NSE) • ✓ Audited Statements (BSE) • ✓ Shareholding LODR (Dec 2024) • 100% Coverage

Domain / Module	Primary Source	Reported Period	Last Sync Time	Audit Status
Live Market Quotes	National Stock Exchange (NSE) / BSE Market Feed	Real-Time	20:35:53 IST	✓ Live Sync
Financial Statements (10Y)	BALKRISHNA IND. Ltd Investor Relations & BSE Filings	Q3 FY25 / Audited FY24	11 Nov 2026	✓ Audited
Shareholding Pattern	Exchange Disclosures (Clause 35 / SEBI LODR)	Dec 2024	11 Nov 2026	✓ Verified
Stock DNA & Valuations	TickerPulse 8-Pillar Scoring & DCF Engine	Current Computed	11 Nov 2026	✓ Deterministic

Save to Your Watchlist

TickerPulse Academy

BALKRISHNA IND. Ltd

🧬 TickerPulse Stock DNA

⚡ What Changed? (Recent Signal Radar)

📈 Price & Technical Intelligence

📐 Key Fundamentals & Valuation Multiples

About BALKRISHNA IND. Ltd

📑 10-Year Comprehensive Financial Statements

🎯 Valuation Lab & Sensitivity Matrix

🛡️ Forensic Audit Radar & Red Flag Monitor

👥 Shareholding Pattern & Institutional Footprint

🤖 Filings & AI Document Intelligence

🧭 Scenario Lab (12-Month Derived Valuation Targets)

🏢 Sector Peer Comparison (Diversified)

Metric Explainer

Stock DNA Methodology

Document Title